http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_ac3e8a08478364a8a337937703a81afc
Outgoing Links
| Predicate | Object |
|---|---|
| family-name | Ellis |
| name | Matthew J Ellis Matthew J. Ellis |
| given-name | Matthew J. Matthew J |
| organization-name | 1Division of Oncology and 2Division of Endocrinology and Metabolism, Department of Medicine, Washington University School of Medicine, St. Louis, Missouri; 3The Broad Institute of MIT and Harvard, Cambridge, Massachusetts; 4Fred Hutchinson Cancer Research Center, Seattle; 5Biological Sciences Division, Pacific Northwest National Laboratory, Richland, Washington; 6Office of Cancer Clinical Proteomics Research, National Cancer Institute, NIH, Bethesda, Maryland; and 7The Jim Ayers Institute for Cancer Detection and Diagnosis, Vanderbilt-Ingram Cancer Center, Nashville, Tennessee. Department of Medicine Baylor University College of Medicine Houston Texas USA Division of Oncology, Department of Internal Medicine, Washington University in St Louis, St Louis, MO Department of Medicine, Washington University, St. Louis, Missouri, USA; Authors' Affiliations: 1Section of Breast Oncology, Division of Oncology, Department of Internal Medicine; 2Division of Biostatistics, Washington University in St Louis, School of Medicine; and 3Siteman Comprehensive Cancer Center, St. Louis, Missouri; Authors' Affiliations: 1Section of Breast Oncology, Division of Oncology, Department of Internal Medicine; 2Division of Biostatistics, Washington University in St Louis, School of Medicine; and 3Siteman Comprehensive Cancer Center, St. Louis, Missouri Alfred Hospital, Melbourne, Australia Paul E. Goss and Pedro E.R. Liedke, Massachusetts General Hospital, Boston, MA; James N. Ingle, Mayo Clinic, Rochester, MN; Matthew J. Ellis, Siteman Cancer Center, Washington University, St Louis, MO; George W. Sledge, Indiana University Health, Indianapolis; Rafat H. Ansari, Northern Indiana Cancer Research Consortium, South Bend, IN; G. Thomas Budd, Cleveland Clinic, Cleveland, OH; David B. Johnson, Cancer Center of Kansas, Wichita, KS; Vered Stearns, The Sidney Kimmel Comprehensive Cancer Center at... Siteman Comprehensive Cancer Center and Washington University School of Medicine, St. Louis, MO, USA Authors' Affiliations: 1Department of Biomolecular Engineering and 2Center for Biomolecular Science and Engineering, University of California, Santa Cruz, California; 3Division of Oncology, Department of Internal Medicine, Section of Breast Oncology, and 4Siteman Cancer Center Breast Cancer Program, Washington University, St. Louis, Missouri; Authors' Affiliations: 1Department of Biomolecular Engineering and 2Center for Biomolecular Science and Engineering, University of California, Santa Cruz, California; 3Division of Oncology, Department of Internal Medicine, Section of Breast Oncology, and 4Siteman Cancer Center Breast Cancer Program, Washington University, St. Louis, Missouri Division of Oncology, Siteman Comprehensive Cancer Center, Washington University, St Louis, MO 3Department of Breast Cancer, Baylor College of Medicine, Houston, Texas. Authors' Affiliation: Section of Breast Oncology, Division of Oncology, Department of Medicine, Siteman Cancer Center, Washington University School of Medicine, St. Louis, Missouri From the Division of Breast Surgery, University of Nottingham, Nottingham; Department of Oncology, Ninewells Hospital and Medical School, Dundee; AstraZeneca Pharmaceuticals, Alderley Park, United Kingdom; Hospital Arnau de Vilanova, Lérida, Spain; Centrum Onkologii, Instytut im M. Skłodowskiej-Curie, Krakow, Poland; Fackultni Nemocnice Ostrava, Radioterapeutická klinika, Ostrava-Poruba, Czech Republic; Washington University School of Medicine, St Louis, MO. Divisions of Nephrology and Abdominal Transplant, Departments of Medicine and Surgery, Duke University School of Medicine, Durham, NC, USA Physiology Service, Department of Allergy, Immunology and Respiratory Medicine, The Alfred Hospital, Melbourne; 4Department of Medicine, Washington University, St. Louis, Missouri; Lester and Sue Smith Breast Center, Baylor College of Medicine, Houston, Texas Division of Nephrology, Duke University School of Medicine, Durham, NC. Duke University Breast Cancer Program, Duke University Medical Center, DUMC PO Box 3446, Durham, NC 27710, USA. Division of Oncology, Department of Medicine, Siteman Cancer Center, Washington University School of Medicine, St. Louis, MO 63110, USA 1Graduate Program in Translational Biology and Molecular Medicine, Baylor College of Medicine, Houston, Texas.; 3Lester and Sue Smith Breast Center, Baylor College of Medicine, Houston, Texas.; 8Dan L Duncan Comprehensive Cancer Center, Houston, Texas. Washington University School of Medicine, St. Louis, Missouri;7 From Montefiore Medical Center, Albert Einstein College of Medicine, Bronx, NY (J.A.S., D.F.M.); Dana–Farber Cancer Institute, Boston (R.J.G.); Sunnybrook Research Institute, Toronto (K.I.P.), and McMaster University, Hamilton, ON (T.J.W.) — both in Canada; Loyola University Chicago Stritch School of Medicine, Maywood (K.S.A.), and Northwestern University, Chicago (L.I.W., V.G.K.) — both in Illinois; University of Michigan, Ann Arbor (D.F.H.); Virginia Commonwealth University School of Medicine and the... Authors' Affiliations: 1Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, North Carolina; 2British Columbia Cancer Agency; 3University of British Columbia, Vancouver, British Columbia; 4NCIC Clinical Trials Group, Kingston; 5McMaster University, Hamilton; 6Sunnybrook Odette Cancer Centre, Toronto, Ontario, Canada; 7Washington University, St Louis, Missouri; and 8University of Utah Health Sciences Center, Salt Lake City, Utah Department of Internal Medicine, Washington University School of Medicine, St. Louis, Missouri 63110, United States Lester and Sue Smith Breast Center, Baylor College of Medicine, Houston, TX 77030, USA Lester and Sue Smith Breast Center, Baylor College of Medicine, Houston, TX, USA. Department of Medicine, Duke University, Durham, North Carolina; Department of Surgery, Duke University, Durham, North Carolina 15Lester and Sue Smith Breast Center, Baylor College of Medicine, Houston, Texas. From the Siteman Cancer Center; Washington University, St Louis, MO; American College of Surgeons Oncology Group Statistical Center, Mayo Clinic, Rochester, MN; Linberger Cancer Center, University of North Carolina, Chapel Hill; Duke University Cancer Center, Durham, NC; Helen Diller Cancer Center, University of California San Francisco, San Francisco, CA; Doctors Hospital of Laredo, Laredo; University of Texas MD Anderson Cancer Center, Houston; Simmons Cancer Center, University of Texas Southwestern,... 7Lester and Sue Smith Breast Center, Baylor College of Medicine, Houston, Texas. From the Sarah Cannon Research Institute, Nashville, TN; Division of Hematology/Oncology, University of North Carolina at Chapel Hill, Chapel Hill; Duke University Medical Center, Durham; GlaxoSmithKline Inc, Research Triangle Park, NC; and Case Western Reserve University, Cleveland, OH From the Mayo Clinic, Rochester, MN; Massachusetts General Hospital Cancer Center, Harvard University, Boston, MA; RIKEN Center for Genomic Medicine, Tokyo, Japan; NCIC Clinical Trials Group, Kingston; Sunnybrook Odette Regional Cancer Centre, University of Toronto, Toronto, Ontario, Canada; Washington University, St Louis, MO; Indiana University, Indianapolis, IN; Johns Hopkins School of Medicine, Baltimore, MD; and Ohio State University Medical Center, Columbus, OH. Authors' Affiliations: 1Division of Oncology, Department of Medicine, Washington University in Saint Louis; 2Siteman Comprehensive Cancer Center, St. Louis, Missouri; Authors' Affiliations: 1Division of Oncology, Department of Medicine, Washington University in Saint Louis; 2Siteman Comprehensive Cancer Center, St. Louis, Missouri 6Lester and Sue Smith Breast Center, Baylor College of Medicine, Houston, Texas. 3Department of Medicine, Division of Oncology, Washington University School of Medicine, St. Louis, Missouri.; 7Lester and Sue Smith Breast Care Center, Oncology/Medicine and MCB, Baylor College of Medicine, Houston, Texas. Duke University Comprehensive Cancer Center, Campus Box 8056, 660 South Euclid, Durham, NC 27710, USA. [email protected] Department of Respiratory Medicine Alfred Health Melbourne Victoria Australia From Montefiore Medical Center, Albert Einstein College of Medicine, Bronx, NY (J.A.S., D.F.M.); Dana–Farber Cancer Institute, Boston (R.J.G.); University of Texas, San Antonio (P.M.R.); Sunnybrook Research Institute, Toronto (K.I.P.), and McMaster University, Hamilton, ON (T.J.W.) — both in Canada; Loyola University Medical Center, Maywood (K.S.A.), and Northwestern University, Chicago (L.I.W., V.G.K.) — both in Illinois; University of Michigan, Ann Arbor (D.F.H.); Virginia Commonwealth University... Department of Medicine Baylor College of Medicine Houston TX; Lester and Sue Smith Breast Center Baylor College of Medicine Houston TX; Interdepartmental Graduate Program in Translational Biology and Molecular Medicine Baylor College of Medicine Houston TX; Dan L. Duncan Comprehensive Cancer Center Baylor College of Medicine Houston TX 1Breast Cancer Program,; 2Departments of Oncology, Baylor College of Medicine, Houston, Texas Washington University, St Louis, Missouri; (now at) Baylor College of Medicine, Houston, Texas From the Royal Marsden Hospital; Breakthrough Breast Cancer Research Centre, Institute of Cancer Research; and Cancer Research United Kingdom Clinical Trials and Statistics Unit, Section of Clinical Trials, Institute of Cancer Research, London, United Kingdom; Lineberger Comprehensive Cancer Center and Department of Genetics, University of North Carolina at Chapel Hill, Chapel Hill, NC; and Washington University and Siteman Cancer Center, St Louis, MO. Rodrigo Goncalves, Faculdade de Medicina da Universidade de São Paulo, São Paulo, Brazil; Tomás Reinert, Hospital do Câncer Mãe de Deus, Universidade Federal do Rio Grande do Sul, Porto Alegre, Brazil; and Matthew J. Ellis, Baylor College of Medicine, Houston, TX Authors' Affiliations: 1Genetic Pathology Evaluation Centre, Vancouver Coastal Health Research Institute, British Columbia Cancer Agency, and University of British Columbia, Vancouver, British Columbia, Canada; 2Lineberger Comprehensive Cancer Center and Departments of Genetics, and Pathology and Laboratory Medicine, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina; 3Department of Pathology, University of Utah Health Sciences Center, Salt Lake City, Utah; and 4Department of Genetics, The Genome Center, Washington University School of Medicine, St Louis, Missouri; 5Department of Medicine, Division of Oncology, Washington University School of Medicine, St Louis, Missouri; 6Siteman Comprehensive Cancer Center, Washington University School of Medicine and Barnes-Jewish Hospital, St Louis, Missouri; Authors' Affiliations: 1Genetic Pathology Evaluation Centre, Vancouver Coastal Health Research Institute, British Columbia Cancer Agency, and University of British Columbia, Vancouver, British Columbia, Canada; 2Lineberger Comprehensive Cancer Center and Departments of Genetics, and Pathology and Laboratory Medicine, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina; 3Department of Pathology, University of Utah Health Sciences Center, Salt Lake City, Utah; and 4Department of Genetics, The Genome Center, Washington University School of Medicine, St Louis, Missouri; 5Department of Medicine, Division of Oncology, Washington University School of Medicine, St Louis, Missouri; 6Siteman Comprehensive Cancer Center, Washington University School of Medicine and Barnes-Jewish Hospital, St Louis, Missouri Monash UniversityMelbourne, Victoria, Australia Department of Internal Medicine Baylor College of Medicine Houston Texas 5Lester and Sue Smith Breast Center, Baylor College of Medicine, Houston, Texas. Lester and Sue Smith Breast Center, Baylor College of Medicine Houston Texas 8Lester and Sue Smith Breast Center, Baylor College of Medicine, Houston, Texas. 14Lester and Sue Smith Breast Center, Baylor College of Medicine, Houston, Texas. 3Baylor Breast Center, Houston, Texas. Siteman Comprehensive Cancer Center, Washington University School of Medicine, St. Louis, MO 63110; and From the Department of Pathology (Drs Jorns and Thomas) and Comprehensive Cancer Center (Mr Healy and Ms Daignault), University of Michigan, Ann Arbor; the Genome Institute (Ms Vickery and Dr Mardis) and Division of Oncology (Ms Snider and Drs Davies and Ellis), Washington University School of Medicine, St Louis, Missouri; and the Department of Laboratory Medicine and Pathology (Dr Visscher), Mayo Medical Laboratories, Rochester, Minnesota. Authors' Affiliation: Siteman Cancer Center, Washington University School of Medicine, St. Louis, Missouri Department of Medicine, Duke University, Durham, NC. Siteman Cancer Center, Washington University, St Louis, Missouri 63110, USA.;Breast Cancer Program, Washington University, St Louis, Missouri 63110, USA.;Department of Internal Medicine, Division of Oncology, Washington University, St Louis, Missouri 63110, USA. Matthew J. Ellis and Chad J. Creighton, Baylor College of Medicine; Gildy Babiera and Kelly Hunt, MD Anderson Cancer Center, Houston; Gary Unzeitig, Doctor's Hospital of Laredo, Laredo; Marilyn Leitch, University of Texas Southwestern Campus, Dallas, TX; Vera J. Suman, Mayo Clinic, Rochester MN; Jeremy Hoog, Rodrigo Goncalves, Souzan Sanati, Katherine DeSchryver, Erika Crouch, Amy Brink, Mark Watson, Jingqin Luo, Yu Tao, Cynthia X. Ma, and D. Craig Allred, Washington University School of Medicine, St... From the Siteman Comprehensive Cancer Center, Washington University School of Medicine, St Louis, MO; Duke University Medical Center, Durham, NC; Edinburgh Breast Unit, Edinburgh University, Edinburgh, Scotland; Royal Marsden Hospital, London, United Kingdom; and Novartis Pharma AG, Basel, Switzerland. 2Lester and Sue Smith Breast Center, Baylor College of Medicine, Houston, Texas. Division of Oncology (M.J.E.), Department of Medicine, Washington University School of Medicine, St Louis, Missouri 63110 Washington University School of Medicine, St. Louis, Missouri Authors' Affiliations: 1Department of Pathology, Saint Barnabas Medical Center, Livingston, New Jersey; 2Department of Pathology, University of Colorado, Denver, Colorado; 3Institute of Pharmacogenomics and Individualized Therapy, Eshelman School of Pharmacy, 4Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill; 5Cancer and Leukemia Group B Statistical Center, Duke University Medical Center, Durham, North Carolina; 6Department of Pathology, Mount Sinai Medical Center; 7Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York; 8Department of Medical Oncology, Fox Chase Cancer Center, Philadelphia, Pennsylvania; 9Department of Medical Oncology, The Angeles Clinic and Research Institute, Santa Monica, California; 10Department of Medical Oncology, Mayo Clinic, Rochester, Minnesota; 11Department of Medical Oncology, University of California, San Francisco, California; 12Department of Medical Oncology, Dana Farber Cancer Institute, Boston, Massachusetts; 13Department o Division of Oncology, Department of Internal Medicine, Washington University School of Medicine, St. Louis, Missouri; The Alvin J. Siteman Cancer Center, Washington University School of Medicine, St. Louis, Missouri Department of Medicine, Monash University, Melbourne, Victoria, Australia Division of Nephrology Department of Medicine Duke University School of Medicine Durham NC USA Department of Surgery Duke University Medical Center Box 3512 27710 Durham NC USA; Division of Nephrology, Department of Medicine Duke University Medical Center Durham NC USA Department of Medicine Duke University Health System Durham NC USA; Department of Surgery Duke University Health System Durham NC USA Section of Breast Oncology, Division of Oncology, Department of Medicine, Siteman Cancer Center, Washington University School of Medicine, 660 South Euclid Avenue, St. Louis, MO 63110, USA Baylor College of Medicine, Houston, TX From the Department of Discovery Medicine and Clinical Pharmacology, GlaxoSmithKline, Research Triangle Park; Division of Hematology-Oncology, Duke University Medical Center, Durham; Lineberger Comprehensive Cancer Center, University of North Carolina-Chapel Hill, Chapel Hill, NC; Tennessee Oncology Associates, Sarah Cannon Cancer Center, Nashville, TN; Division of Hematology-Oncology, Case Western Reserve Medical School, Cleveland, OH; Prediction Sciences, San Diego, CA; Quantitative Diagnostics... 2Siteman Cancer Center, Washington University School of Medicine, St. Louis, Missouri; Duke University Medical Center Durham NC USA Lester and Sue Smith Breast Center Baylor College of Medicine Houston Texas Authors' Affiliations: 1Department of Medical Oncology, British Columbia Cancer Agency (BCCA); 2Department of Pathology, University of British Columbia, Vancouver, British Columbia; 3Department of Medical Oncology, Tom Baker Cancer Centre, Calgary, Alberta; 4NCIC Clinical Trials Group (CTG), Kingston; 5Department of Medical Oncology, Sunnybrook Odette Cancer Centre, Toronto, Ontario, Canada; 6Genome Sequencing Facility and Division of Oncology, Washington University School of Medicine, St. Louis, Missouri; 7Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina; and 8Department of Pathology, University of Utah Health Sciences Center, Salt Lake City, Utah Matthew J. Ellis, Baylor College of Medicine, Houston, TX; Antonio Llombart-Cussac, Hospital Arnau de Vilanova, Lérida, Spain; David Feltl, FNsP Ostrava, Ostrava-Poruba, Czech Republic; John A. Dewar, Ninewells Hospital and Medical School, Dundee; Nicola Hewson and Yuri Rukazenkov, AstraZeneca Pharmaceuticals, Macclesfield; John F.R. Robertson, University of Nottingham, Derby, United Kingdom; and Marek Jasiówka, Instytut im Marii Skłodowskiej-Curie, Kraków, Poland. 1Medicine, Division of Oncology, Departments of; 4Siteman Comprehensive Cancer Center, St. Louis, Missouri; Authors' Affiliations: 1Division of Medical Oncology, Section of Breast Oncology, Siteman Cancer Center, Washington University School of Medicine;2University Genomics;3Bioclassifier LLC, St. Louis, Missouri; and 4Department of Genetics, Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, North Carolina; Authors' Affiliations: 1Division of Medical Oncology, Section of Breast Oncology, Siteman Cancer Center, Washington University School of Medicine;2University Genomics;3Bioclassifier LLC, St. Louis, Missouri; and 4Department of Genetics, Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, North Carolina; Authors' Affiliations: 1Division of Medical Oncology, Section of Breast Oncology, Siteman Cancer Center, Washington University School of Medicine;2University Genomics;3Bioclassifier LLC, St. Louis, Missouri; and 4Department of Genetics, Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, North Carolina Lester and Sue Smith Breast Center, Baylor College of Medicine, Houston, TX Division of Nephrology Department of Medicine Duke University School of Medicine Durham North Carolina From the Duke University Comprehensive Cancer Center, Durham, NC; Lombardi Cancer Center, Washington DC; Institut Bergonié, Bordeaux Cedex, France; Instituto Valenciano de Oncologia, Valencia, Spain; Universitaets Frauen-und Poliklinik UKE, Hamburg, Germany; Breast Research Unit, Western General Hospital, Edinburgh, United Kingdom; Novartis Pharma AG, Basel, Switzerland; and Novartis Pharmaceuticals, East Hanover, NJ. Authors' Affiliations: Departments of 1Biochemistry & Molecular Biology, 2Orthopaedic Surgery, and 3Medicine, 4Institute for Genetic Medicine, 5USC Epigenome Center and 6Norris Comprehensive Cancer Center, Keck School of Medicine of the University of Southern California, Los Angeles, California; and 7Division of Biostatistics, 8Siteman Cancer Center Breast Cancer Program, Washington University, St Louis, Missouri Maura N. Dickler, Mary Ellen Moynahan, Diana E. Lake, and Clifford A. Hudis, Memorial Sloan Kettering Cancer Center, New York, NY; William T. Barry, Dana-Farber Cancer Institute; Eric P. Winer, Dana-Farber/Partners Cancer Care, Boston, MA; Constance T. Cirrincione, Duke University, Durham, NC; Matthew J. Ellis, Baylor College of Medicine; Debasish Tripathy, The University of Texas MD Anderson Cancer Center, Houston, TX; Federico Innocenti and Lisa A. Carey, University of North Carolina at Chapel Hill,... Duke University Clinical Breast Cancer Program at Duke University Medical Center, Durham, North Carolina. Vered Stearns, Kimmel Cancer Center, Johns Hopkins, Baltimore, MD; Judith-Anne W. Chapman, Aurélie Le Maitre, Jessica Kundapur, and Lois E. Shepherd, NCIC Clinical Trials Group, Queen's University, Kingston; Kathleen I. Pritchard, Sunnybrook Odette Cancer Centre and University of Toronto, Toronto, Ontario, Canada; Cynthia X. Ma, Siteman Cancer Center, Washington University, St Louis, MO; Matthew J. Ellis, Lester and Sue Smith Breast Center, Baylor College of Medicine, Houston, TX; James N. Ingle, Mayo... Lester and Sue Smith Breast Center, Baylor College of Medicine, One Baylor Plaza, 320A Cullen, MS 600, 77030, Houston, TX, USA. [email protected]. Department of Medicine, Duke University Medical Center, Durham, NC. Department of Mathematics, Lion Terrace, Buckingham Building, University of Portsmouth, Portsmouth, PO1 3HE, and Centre for Molecular Design, Institute of Biomedical and Biomolecular Science, University of Portsmouth, King Henry I Street, Portsmouth PO1 2DY From the Lineberger Comprehensive Cancer Center and Departments of Genetics, Pathology and Laboratory Medicine, and Department of Statistics and Operations Research, Carolina Center for Genome Sciences, University of North Carolina at Chapel Hill, Chapel Hill, NC; Department of Pathology, University of Utah Health Sciences Center; ARUP Institute for Clinical and Experimental Pathology, Salt Lake City, UT; Genetic Pathology Evaluation Centre, Department of Pathology, Vancouver Coastal Health Research... 12Lester and Sue Smith Breast Center, Dan L. Duncan Comprehensive Cancer Center and Departments of Medicine and Molecular and Cellular Biology, Baylor College of Medicine, Houston, Texas. Section of Breast Oncology, Division of Oncology, Department of Medicine, Washington University School of Medicine, St. Louis, MO, USA; Siteman Cancer Center, Washington University School of Medicine, St. Louis, MO, USA Department of Oncology, Baylor College of Medicine, Houston, Texas 1Lester and Sue Smith Breast Center, Baylor College of Medicine, Houston, Texas.; 2Department of Medicine, Baylor College of Medicine, Houston, Texas. Allergy, Immunology & Respiratory Medicine; The Alfred; Melbourne Australia Authors' Affiliations: 1Division of Oncology, Department of Medicine; 2Siteman Cancer Center; 3The Genome Institute; and 4Department of Genetics, Washington University School of Medicine, St. Louis, Missouri; Authors' Affiliations: 1Division of Oncology, Department of Medicine; 2Siteman Cancer Center; 3The Genome Institute; and 4Department of Genetics, Washington University School of Medicine, St. Louis, Missouri |
Incoming Links
Showing number of triples: 1 to 365 of 365.